1Gorgun G, Miller KB, Foss FM. Immunologic mechanisms of exlracorporeal photochcmotherapy in chronic graft versus host disease[J].Blood,2002,100(3):941-947.
2Foss FM,Gorgun G, Miller KB. Extracorporeal photopheresis in chronic graft wersus host disease [J]. Bone Marrow Transplant,200E,29(9):719-725.
3Edelson R,Berger C,Gasparro F,et al. Treatment of cutaneous T cell lymphoma by extracorporeal photochemotherapy. Preliminary resuhs[J].N Engl J Med,1987,316(6) :297 -303.
4Owsianowski M, Gollnick H, Siegert W, et al. Successful treatment of chronic graft versus host disease with extracorporeal photopheresis[J]. Bone Marrow Transplant, 1994,14(5) :845-848.
5Rosetti F, Dall' Amico R, Grovetti G, et al. Extracorporeal photochemotherapy for the treatment of graft versus-host disease[J]. Bone Marrow Transplant,1996,18(Suppl 2) :S175- S181.
6Perotti C,Torretta L, Viarengo G,et al. Feasibility and safety of a new technique of extracorporeal photochemotherapy: experience of 240 procedures[J].Haematologica, 1999,4(3) : 237-241.
7Biagi E, Perseghin P, Buscemi F, et al. Effectiveness of extracorporcal photochemotherapy in treating refractory chronic graft versus host disease[J].Haematologica, 2000,85 (3):329-330.
8Greinix HT,Volc-Platzer B, Rabitsch W,et al. Successful use of extracorporeal photochemotherapy in the treatment of severe acute and chronic graft-versus-host disease[J]. Blood, 1998,92(9):3098- 3104.
9Apisarnthanarax N, Donato M, Korbling M, et al. Extracorporeal photopheresis therapy in the management of steroid refractory or steroid-dependent cutaneous chronic graft versus-host disease after allogeneic stem cell transplantation: feasibility and results[J].Bone Marrow Transplant, 2003,31 (6) :459-465.
10Foss FM,Di Vcnuti C-M.Chin K, et al. Prospective study of extracorporeal photopheresis in steroid refractory or steroid resistant extensive chronic graft versus host disease: analysis of response and survival incorporating prognostic factors[J].Bone Marrow Transplant, 2005,35(12) : 1187-1193.
